Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: Sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla

This publication has 35 references indexed in Scilit:

• Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Discovery of a Potent, Selective, and Efficacious Class of Reversible α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Effective as Analgesics
  Journal of Medicinal Chemistry, 2004
• Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats
  Neuropharmacology, 2003
• Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system
  Current Opinion in Chemical Biology, 2003
• Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
  Proceedings of the National Academy of Sciences, 2001
• Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide Hydrolase
  Biochemical and Biophysical Research Communications, 1998
• Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand
  FEBS Letters, 1998
• Activated Ketones as Inhibitors of Intracellular Ca²⁺-Dependent and Ca²⁺-Independent Phospholipase A₂
  Journal of the American Chemical Society, 1996
• The Many Possible Roles of Opioids and Related Peptides in Stress‐Induced Analgesia^a
  Annals of the New York Academy of Sciences, 1986
• Evidence for opioid and non-opioid forms of stimulation-produced analgesia in the rat
  Brain Research, 1982